| |
Normal range |
Baseline |
4 weeks after amazake intake |
8 weeks after amazake intake |
12 weeks after amazake intake |
| BMI (kg/m2) |
|
21.0 ± 2.0 |
21.1 ± 2.1 |
21.1 ± 2.1 |
21.1 ± 1.9 |
| WBC (μL) |
4000-9000 |
3775.0 ± 1302.2 |
4425.0 ± 1621.5 |
4625.0 ± 2376.8 |
6250.0 ± 4197.2 |
| Neutrophil count (%) |
40.0-70.0 |
47.5 ± 12.1 |
57.3 ± 11.7 |
56.1 ± 17.7 |
56.3 ± 20.0 |
| Eosinophil count (%) |
2.0-4.0 |
4.0 ± 2.5 |
3.4 ± 2.7 |
4.5 ± 4.3 |
4.8 ± 5.3 |
| Basophil count (%) |
0.0-1.0 |
0.8 ± 0.3 |
0.8 ± 0.4 |
0.6 ± 0.7 |
0.7 ± 0.5 |
| Lymphocyte counts (%) |
30.0-43.0 |
39.5 ± 10.3 |
31.3 ± 9.2 |
31.6 ± 11.4 |
30.1 ± 13.6 |
| Monocyte count (%) |
3.0-6.0 |
8.3 ± 2.9 |
7.3 ± 1.9 |
7.2 ± 3.0 |
8.1 ± 2.5 |
| RBC (x10-4/μL) |
Male: 430-570, Female: 380-500 |
410.8 ± 21.9 |
404.5 ± 29.3 |
404.0 ± 14.0 |
409.8 ± 21.1 |
| Hb (g/dL) |
Male: 14.0-18.0, Female: 11.0-15.0 |
13.0 ± 0.9 |
12.8 ± 1.2 |
12.6 ± 0.7 |
12.6 ± 1.1 |
| Plt (x10-4/μL) |
13.0-36.0 |
10.4 ± 3.4 |
9.8 ± 2.8 |
10.1 ± 3.3 |
11.3 ± 4.2 |
| PT (%) |
70-130 |
83.0 ± 14.1 |
80.0 ± 14.5 |
80.5 ± 13.6 |
81.0 ± 15.5 |
| AST (U/L) |
13-33 |
62.3 ± 29.4 |
65.8 ± 31.4 |
58.3 ± 24.8 |
58.5 ± 24.0 |
| ALT (U/L) |
6-30 |
43.5 ± 23.5 |
44.5 ± 22.5 |
38.3 ± 19.7 |
41.3 ± 21.6 |
| γGTP (U/L) |
10-47 |
24.5 ± 13.5 |
24.8 ± 14.0 |
24.8 ± 16.0 |
26.3 ± 15.7 |
| ALP (U/L) |
115-359 |
403.5 ± 184.2 |
456.8 ± 246.4 |
415.3 ± 213.4 |
417.3 ± 156.9 |
| LDH (U/L) |
119-229 |
228.3 ± 21.8 |
228.0 ± 25.5 |
238.5 ± 28.8 |
233.5 ± 19.4 |
| ChE (U/L) |
214-466 |
203.5 ± 58.6 |
199.8 ± 63.3 |
192.0 ± 50.8 |
194.3 ± 54.7 |
| T. pro (g/dL) |
6.70-8.30 |
7.86 ± 0.39 |
7.74 ± 0.62 |
7.71 ± 0.36 |
7.86 ± 0.42 |
| Alb (g/dL) |
4.00-5.00 |
3.61 ± 0.40 |
3.53 ± 0.37 |
3.52 ± 0.38 |
3.57 ± 0.41 |
| BTR |
4.4-10.0 |
3.9 ± 1.5 |
3.6 ± 1.2 |
3.0 ± 0.9 |
3.1 ± 1.2 |
| BCAA (μmol/L) |
344.0-713.0 |
392.7 ± 70.1 |
417.5 ± 38.5 |
352.3 ± 83.5 |
366.3 ± 69.9 |
| TVR (μmol/L) |
51.0-98.0 |
110.4 ± 37.7 |
125.6 ± 45.0 |
124.4 ± 52.8 |
124.5 ± 37.8 |
| T.Bil (mg/dL) |
0.30-1.20 |
1.21 ± 0.38 |
1.05 ± 0.32 |
1.14 ± 0.34 |
1.14 ± 0.35 |
| D.Bil (mg/dL) |
<=0.60 |
0.14 ± 0.05 |
0.12 ± 0.05 |
0.11 ± 0.03 |
0.13 ± 0.07 |
| BUN (mg/dL) |
8.0-22.0 |
13.1 ± 5.8 |
14.8 ± 5.7 |
12.8 ± 4.2 |
14.2 ± 4.0 |
| Crea (mg/dL) |
Male: 0.60-1.10, Female: 0.40-0.70 |
0.63 ± 0.11 |
0.61 ± 0.09 |
0.62 ± 0.10 |
0.63 ± 0.10 |
| AFP (ng/mL) |
<=8.7 |
3.4 ± 2.0 |
4.0 ± 1.9 |
3.6 ± 2.3 |
4.1 ± 2.9 |
| PIVKAII (mAU/mL) |
<=40 |
10.8 ± 4.7 |
11.0 ± 4.1 |
10.5 ± 4.7 |
12.0 ± 4.5 |
| NH3 (μg/dL) |
12-66 |
48.3 ± 32.1 |
48.8 ± 30.6 |
48.3 ± 30.0 |
49.8 ± 32.1 |
| CRP (mg/dL) |
<=0.20 |
0.10 ± 0.08 |
0.10 ± 0.07 |
0.07 ± 0.04 |
0.08 ± 0.05 |
| Na (mmol/L) |
138-146 |
141.5 ± 1.3 |
140.8 ± 1.0 |
140.8 ± 1.0 |
140.8 ± 2.1 |
| K (mmol/L) |
3.6-4.9 |
4.2 ± 0.2 |
4.2 ± 0.3 |
4.1 ± 0.3 |
4.0 ± 0.4 |
| Cl (mmol/L) |
99-109 |
105.5 ± 0.6 |
105.8 ± 1.0 |
106.3 ± 1.7 |
105.8 ± 1.3 |
| TC (mg/dL) |
128-219 |
151.3 ± 15.8 |
158.3 ± 22.4 |
154.0 ± 17.1 |
162.8 ± 28.3 |
| TG (mg/dL) |
30-149 |
91.0 ± 18.7 |
100.5 ± 36.5 |
91.8 ± 22.4 |
102.5 ± 52.0 |
| LDL-C (mg/dL) |
<=139.0 |
78.6 ± 29.2 |
76.9 ± 28.5 |
75.7 ± 19.3 |
81.0 ± 26.4 |
| FBS (mg/dL) |
80-109 |
106.5 ± 5.8 |
105.5 ± 16.6 |
101.8 ± 9.9 |
100.5 ± 10.7 |
| HbA1c (%) |
4.3-5.8 |
5.3 ± 0.3 |
5.3 ± 0.2 |
5.3 ± 0.2 |
5.4 ± 0.2 |
| IRI (μU/mL) |
5.0-20.0 |
8.5 ± 5.7 |
11.9 ± 8.3 |
10.0 ± 6.4 |
13.9 ± 8.3 |
| HOMA-IR |
< 5.4 |
2.2 ± 1.5 |
3.2 ± 2.4 |
2.5 ± 1.7 |
3.4 ± 2.2 |
| Zinc (μg/dL) |
80-130 |
66.8 ± 18.3 |
60.3 ± 17.1 |
59.0 ± 11.7 |
57.5 ± 16.2 |
